SlideShare a Scribd company logo
1 of 24
Historical Milestones in
Hypertension and its Management
Dr. Nagula Praveen
MD,DM
Associate Professor of Cardiology
Osmania General Hospital
Hyderabad
Study the past, if you would define the future.
- Confucius
WILLIAM HARVEY
English Physician
Circulation of the Heart
and Blood
1628
STEPHEN HALES
English Clergyman
First person to
measure blood pressure
1733
RIVA ROCCI
Italian
Mercury sphygmomanometer
1896
N.C. KOROTKOFF
Russian
1905
reported on the
method of
auscultation of
brachial artery, the
method which is
widely used today.
The term essential hypertension ('Essentielle Hypertonie')
was coined by Eberhard Frank in 1911 to describe
elevated blood pressure for which no cause could be found.
Thomas Young -
Hypertension as a disease 1808
Malignant hypertension, a term used to describe severe
hypertension which eventually resulted in death, was first
used by The Mayo Clinic in 1928.
“Hypertension may be an important compensatory
mechanism which should not be tampered with, even were it
certain that we could control it”.
–Paul Dudley White, Father of Preventive Cardiology.
FRANKLIN D. ROOSEVELT
The 32nd President of the United States
President Franklin D. Roosevelt was given a clean bill
of health by his physician even when his BP was
recorded as ~220/120.
A few years later while at Yalta, Winston Churchill’s
personal physician noted in his diary that President
Roosevelt “appeared to be have had signs of
‘hardening of the arteries disease’ and had a few
months to live.”
President Roosevelt ultimately had a fatal
hemorrhagic stroke 2 months later, and his death
brought hypertension’s potential as a deadly to the
limelight.
Three years after Roosevelt’s death, the pivotal
National Heart Act was signed into law by President
Truman. The Act created the path for the study of
heart diseases and resulted in several studies
including the Framingham Heart Study.
Timeline of Hypertension History
Schematic model of the evolution of understanding and
approaches to hypertension in the 20th century.
First sphygmograph
Miguel Ondetti and David
Cushman, 1975 developed
Captopril, the first of a new class of
drugs known as angiotensin
converting enzyme (ACE) inhibitors.
James Whyte Black, 1962
Developed propranolol, a beta blocker
used for the treatment of heart disease
I wish I had my betablockers handy
-Dr. James Black, 1988
Evolution of Blood Pressure Clinical Practice
Guidelines
Conclusion:
This study showed the clinical efficacy, safety and acceptability of the
perindopril/indapamide/amlodipine SPC in patients with grade 2/3 hypertension inadequately
controlled with two drug therapy. The clinical effectiveness was observed in more than 96%
patients. The benefit of SPC therapy in hypertension control was reconfirmed in this study.
Hypertension Screening on Occasion
of World Hypertension Day 2022
• Of the approximately 4500 patients screened, around 800+
patients were screened at OGH, Hyderabad.
3565
922
Males Females
21
846
1723 1918
0
500
1000
1500
2000
2500
Hypertension
Normal
Pre
Hypertension
Hypertension
42.74%
38.39%
17.45%
Prehypertension is defined as a systolic pressure from 120-139 mmHg
and diastolic 80-89 mmHg
22
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
BMI
≥24.0 kg/m2 (Over weight/Obesity)
> = 24.0(over
weight/Obesity)
70.8 %
23
0
200
400
600
800
1000
1200
1400
1600
1800
2000
Diabetes
33 % are Diabetics
HISTORICAL ASPECTS OF HYPERTENSION

More Related Content

What's hot

Combination Therapy In Hypertension - Dr Vivek Baliga Presentation
Combination Therapy In Hypertension - Dr Vivek Baliga PresentationCombination Therapy In Hypertension - Dr Vivek Baliga Presentation
Combination Therapy In Hypertension - Dr Vivek Baliga PresentationDr Vivek Baliga
 
Recent advances in treatment of htn
Recent advances in treatment of htnRecent advances in treatment of htn
Recent advances in treatment of htnchandiniyrao
 
Update in hypertension management
Update in hypertension managementUpdate in hypertension management
Update in hypertension managementTarek Khalil
 
DIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUM
DIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUMDIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUM
DIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUMPraveen Nagula
 
Lipid lowering trials ppt
Lipid lowering trials pptLipid lowering trials ppt
Lipid lowering trials pptNavin Agrawal
 
Hypertension Management - ESC/ESH 2018 guidelines
Hypertension Management - ESC/ESH 2018 guidelinesHypertension Management - ESC/ESH 2018 guidelines
Hypertension Management - ESC/ESH 2018 guidelinesPardhuBharath1
 
Hypertension: New Concepts, Guidelines, and Clinical Management Hypertensio...
Hypertension: New Concepts, Guidelines, and Clinical Management 	 Hypertensio...Hypertension: New Concepts, Guidelines, and Clinical Management 	 Hypertensio...
Hypertension: New Concepts, Guidelines, and Clinical Management Hypertensio...MedicineAndFamily
 
Essential hypertension management and treatment
Essential hypertension management  and treatmentEssential hypertension management  and treatment
Essential hypertension management and treatmentFabio Grubba
 
Hypertension management 2018
Hypertension management  2018Hypertension management  2018
Hypertension management 2018Monkez M Yousif
 
Treatment Of Hypertension In Special Situation Modified Fina Lc
Treatment Of Hypertension In Special Situation Modified Fina LcTreatment Of Hypertension In Special Situation Modified Fina Lc
Treatment Of Hypertension In Special Situation Modified Fina Lcdrmisbah83
 
Hypertension update 2018
Hypertension update 2018Hypertension update 2018
Hypertension update 2018Mahfuzul Islam
 
Lifestyle and heart disease
Lifestyle and heart diseaseLifestyle and heart disease
Lifestyle and heart diseaseashwani mehta
 

What's hot (20)

Combination Therapy In Hypertension - Dr Vivek Baliga Presentation
Combination Therapy In Hypertension - Dr Vivek Baliga PresentationCombination Therapy In Hypertension - Dr Vivek Baliga Presentation
Combination Therapy In Hypertension - Dr Vivek Baliga Presentation
 
Recent advances in treatment of htn
Recent advances in treatment of htnRecent advances in treatment of htn
Recent advances in treatment of htn
 
Jupiter Trial
Jupiter TrialJupiter Trial
Jupiter Trial
 
Update in hypertension management
Update in hypertension managementUpdate in hypertension management
Update in hypertension management
 
DIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUM
DIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUMDIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUM
DIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUM
 
Lipid lowering trials ppt
Lipid lowering trials pptLipid lowering trials ppt
Lipid lowering trials ppt
 
Hypertension Management - ESC/ESH 2018 guidelines
Hypertension Management - ESC/ESH 2018 guidelinesHypertension Management - ESC/ESH 2018 guidelines
Hypertension Management - ESC/ESH 2018 guidelines
 
Hypertension: New Concepts, Guidelines, and Clinical Management Hypertensio...
Hypertension: New Concepts, Guidelines, and Clinical Management 	 Hypertensio...Hypertension: New Concepts, Guidelines, and Clinical Management 	 Hypertensio...
Hypertension: New Concepts, Guidelines, and Clinical Management Hypertensio...
 
Hypertension
HypertensionHypertension
Hypertension
 
Essential hypertension management and treatment
Essential hypertension management  and treatmentEssential hypertension management  and treatment
Essential hypertension management and treatment
 
RESISTANT HYPERTENSION
RESISTANT HYPERTENSIONRESISTANT HYPERTENSION
RESISTANT HYPERTENSION
 
Hypertension management 2018
Hypertension management  2018Hypertension management  2018
Hypertension management 2018
 
Treatment Of Hypertension In Special Situation Modified Fina Lc
Treatment Of Hypertension In Special Situation Modified Fina LcTreatment Of Hypertension In Special Situation Modified Fina Lc
Treatment Of Hypertension In Special Situation Modified Fina Lc
 
Hypertension
HypertensionHypertension
Hypertension
 
Ranolazine
RanolazineRanolazine
Ranolazine
 
Hypertension update 2018
Hypertension update 2018Hypertension update 2018
Hypertension update 2018
 
Lifestyle and heart disease
Lifestyle and heart diseaseLifestyle and heart disease
Lifestyle and heart disease
 
Recent advances in dyslipidemia
Recent advances in dyslipidemiaRecent advances in dyslipidemia
Recent advances in dyslipidemia
 
Dapagliflozin- a novel SGLT2 inhibitor
Dapagliflozin- a novel SGLT2 inhibitorDapagliflozin- a novel SGLT2 inhibitor
Dapagliflozin- a novel SGLT2 inhibitor
 
Jnc 7 vs jnc-8
Jnc 7 vs jnc-8Jnc 7 vs jnc-8
Jnc 7 vs jnc-8
 

Similar to HISTORICAL ASPECTS OF HYPERTENSION

Abc books cardiologia abc of-heart_failure
Abc books cardiologia   abc of-heart_failureAbc books cardiologia   abc of-heart_failure
Abc books cardiologia abc of-heart_failureedubruno2015
 
Learning Objectives1. Describe why hypertension and diabet.docx
Learning Objectives1. Describe why hypertension and diabet.docxLearning Objectives1. Describe why hypertension and diabet.docx
Learning Objectives1. Describe why hypertension and diabet.docxSHIVA101531
 
Historical developments; Trends n issues; Legal n ethical issues in d field o...
Historical developments; Trends n issues; Legal n ethical issues in d field o...Historical developments; Trends n issues; Legal n ethical issues in d field o...
Historical developments; Trends n issues; Legal n ethical issues in d field o...Ancy Das
 
Prof. J.P.Das Oration HEART FAILURE
Prof. J.P.Das Oration HEART FAILUREProf. J.P.Das Oration HEART FAILURE
Prof. J.P.Das Oration HEART FAILUREdrucsamal
 
Bloodless Medicine Caring Effectively For Patients Who Decline Blood Transf...
Bloodless Medicine   Caring Effectively For Patients Who Decline Blood Transf...Bloodless Medicine   Caring Effectively For Patients Who Decline Blood Transf...
Bloodless Medicine Caring Effectively For Patients Who Decline Blood Transf...mcolumbus
 
History of cardiology
History of cardiologyHistory of cardiology
History of cardiologyDona Mathew
 
The history of paediatric cardiology
The history of paediatric cardiologyThe history of paediatric cardiology
The history of paediatric cardiologyRamachandra Barik
 
Treatment of myocardial infarction,past& present
Treatment of myocardial infarction,past& presentTreatment of myocardial infarction,past& present
Treatment of myocardial infarction,past& presentAmeel Yaqo
 
Heart disease reversal
Heart disease reversal Heart disease reversal
Heart disease reversal John Bergman
 
History of blood transfusion.pptx
History of blood transfusion.pptxHistory of blood transfusion.pptx
History of blood transfusion.pptxUmesh Prasad Gupta
 
Valvular Heart Disease A Century Of Progress
Valvular Heart Disease A Century Of ProgressValvular Heart Disease A Century Of Progress
Valvular Heart Disease A Century Of Progresskops
 
Blood pressure and cholesterol
Blood pressure and cholesterolBlood pressure and cholesterol
Blood pressure and cholesterolJohn Bergman
 
Soap analysis on Coronary Artery Disease: By RxVichuZ!
Soap analysis on Coronary Artery Disease: By RxVichuZ!Soap analysis on Coronary Artery Disease: By RxVichuZ!
Soap analysis on Coronary Artery Disease: By RxVichuZ!RxVichuZ
 
ECG changes in anorexia nervosa
ECG changes in anorexia nervosaECG changes in anorexia nervosa
ECG changes in anorexia nervosaSimon Daley
 

Similar to HISTORICAL ASPECTS OF HYPERTENSION (20)

Abc books cardiologia abc of-heart_failure
Abc books cardiologia   abc of-heart_failureAbc books cardiologia   abc of-heart_failure
Abc books cardiologia abc of-heart_failure
 
Learning Objectives1. Describe why hypertension and diabet.docx
Learning Objectives1. Describe why hypertension and diabet.docxLearning Objectives1. Describe why hypertension and diabet.docx
Learning Objectives1. Describe why hypertension and diabet.docx
 
Treating angina
Treating anginaTreating angina
Treating angina
 
Historical developments; Trends n issues; Legal n ethical issues in d field o...
Historical developments; Trends n issues; Legal n ethical issues in d field o...Historical developments; Trends n issues; Legal n ethical issues in d field o...
Historical developments; Trends n issues; Legal n ethical issues in d field o...
 
Prof. J.P.Das Oration HEART FAILURE
Prof. J.P.Das Oration HEART FAILUREProf. J.P.Das Oration HEART FAILURE
Prof. J.P.Das Oration HEART FAILURE
 
Bloodless Medicine Caring Effectively For Patients Who Decline Blood Transf...
Bloodless Medicine   Caring Effectively For Patients Who Decline Blood Transf...Bloodless Medicine   Caring Effectively For Patients Who Decline Blood Transf...
Bloodless Medicine Caring Effectively For Patients Who Decline Blood Transf...
 
History of cardiology
History of cardiologyHistory of cardiology
History of cardiology
 
avanços diabetologia.pdf
avanços diabetologia.pdfavanços diabetologia.pdf
avanços diabetologia.pdf
 
Beta blockers
Beta blockersBeta blockers
Beta blockers
 
The history of paediatric cardiology
The history of paediatric cardiologyThe history of paediatric cardiology
The history of paediatric cardiology
 
Treatment of myocardial infarction,past& present
Treatment of myocardial infarction,past& presentTreatment of myocardial infarction,past& present
Treatment of myocardial infarction,past& present
 
CHRONOPHARMACOLOGY
CHRONOPHARMACOLOGYCHRONOPHARMACOLOGY
CHRONOPHARMACOLOGY
 
Heart disease reversal
Heart disease reversal Heart disease reversal
Heart disease reversal
 
History of blood transfusion.pptx
History of blood transfusion.pptxHistory of blood transfusion.pptx
History of blood transfusion.pptx
 
Valvular Heart Disease A Century Of Progress
Valvular Heart Disease A Century Of ProgressValvular Heart Disease A Century Of Progress
Valvular Heart Disease A Century Of Progress
 
HISTORY OF PARATHYROID SURGERY 2021.ppt
HISTORY OF PARATHYROID SURGERY 2021.pptHISTORY OF PARATHYROID SURGERY 2021.ppt
HISTORY OF PARATHYROID SURGERY 2021.ppt
 
Blood pressure and cholesterol
Blood pressure and cholesterolBlood pressure and cholesterol
Blood pressure and cholesterol
 
Anesthesiology
AnesthesiologyAnesthesiology
Anesthesiology
 
Soap analysis on Coronary Artery Disease: By RxVichuZ!
Soap analysis on Coronary Artery Disease: By RxVichuZ!Soap analysis on Coronary Artery Disease: By RxVichuZ!
Soap analysis on Coronary Artery Disease: By RxVichuZ!
 
ECG changes in anorexia nervosa
ECG changes in anorexia nervosaECG changes in anorexia nervosa
ECG changes in anorexia nervosa
 

More from Praveen Nagula

historical aspects of hypertension.pptx
historical aspects of hypertension.pptxhistorical aspects of hypertension.pptx
historical aspects of hypertension.pptxPraveen Nagula
 
Management of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptxManagement of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptxPraveen Nagula
 
ECGs in clinical practice.pptx
ECGs in clinical practice.pptxECGs in clinical practice.pptx
ECGs in clinical practice.pptxPraveen Nagula
 
ATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptxATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptxPraveen Nagula
 
RHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptxRHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptxPraveen Nagula
 
HISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptxHISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptxPraveen Nagula
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementPraveen Nagula
 
Beta blockers all are not same
Beta blockers   all are not sameBeta blockers   all are not same
Beta blockers all are not samePraveen Nagula
 
INTERESTING ECGS -- PART II
INTERESTING ECGS -- PART IIINTERESTING ECGS -- PART II
INTERESTING ECGS -- PART IIPraveen Nagula
 
how low to go with LDL
how low to go with LDL how low to go with LDL
how low to go with LDL Praveen Nagula
 
Heart Failure - What to expect from the Investigations?
Heart Failure - What to expect from the Investigations?Heart Failure - What to expect from the Investigations?
Heart Failure - What to expect from the Investigations?Praveen Nagula
 

More from Praveen Nagula (20)

BIOMARKERS IN HF.pptx
BIOMARKERS IN HF.pptxBIOMARKERS IN HF.pptx
BIOMARKERS IN HF.pptx
 
historical aspects of hypertension.pptx
historical aspects of hypertension.pptxhistorical aspects of hypertension.pptx
historical aspects of hypertension.pptx
 
Management of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptxManagement of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptx
 
ECGs in clinical practice.pptx
ECGs in clinical practice.pptxECGs in clinical practice.pptx
ECGs in clinical practice.pptx
 
PCP IN STEMI.pptx
PCP IN STEMI.pptxPCP IN STEMI.pptx
PCP IN STEMI.pptx
 
ATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptxATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptx
 
8.FEMI.pptx
8.FEMI.pptx8.FEMI.pptx
8.FEMI.pptx
 
RHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptxRHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptx
 
WAVES OF ECG.pptx
WAVES OF ECG.pptxWAVES OF ECG.pptx
WAVES OF ECG.pptx
 
BASICS OF ECG.pptx
BASICS OF ECG.pptxBASICS OF ECG.pptx
BASICS OF ECG.pptx
 
HISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptxHISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptx
 
QUIZ IV
QUIZ IVQUIZ IV
QUIZ IV
 
QUIZ .pptx
QUIZ .pptxQUIZ .pptx
QUIZ .pptx
 
QUIZ
QUIZ QUIZ
QUIZ
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes management
 
Beta blockers all are not same
Beta blockers   all are not sameBeta blockers   all are not same
Beta blockers all are not same
 
INTERESTING ECGS -- PART II
INTERESTING ECGS -- PART IIINTERESTING ECGS -- PART II
INTERESTING ECGS -- PART II
 
how low to go with LDL
how low to go with LDL how low to go with LDL
how low to go with LDL
 
HF update 2021
HF update 2021HF update 2021
HF update 2021
 
Heart Failure - What to expect from the Investigations?
Heart Failure - What to expect from the Investigations?Heart Failure - What to expect from the Investigations?
Heart Failure - What to expect from the Investigations?
 

Recently uploaded

What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPCeline George
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17Celine George
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitolTechU
 
CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxJiesonDelaCerna
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxRaymartEstabillo3
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...JhezDiaz1
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxAvyJaneVismanos
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.arsicmarija21
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentInMediaRes1
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 

Recently uploaded (20)

What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERP
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptx
 
CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptx
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptx
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media Component
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 

HISTORICAL ASPECTS OF HYPERTENSION

  • 1. Historical Milestones in Hypertension and its Management Dr. Nagula Praveen MD,DM Associate Professor of Cardiology Osmania General Hospital Hyderabad
  • 2. Study the past, if you would define the future. - Confucius
  • 3. WILLIAM HARVEY English Physician Circulation of the Heart and Blood 1628 STEPHEN HALES English Clergyman First person to measure blood pressure 1733 RIVA ROCCI Italian Mercury sphygmomanometer 1896 N.C. KOROTKOFF Russian 1905 reported on the method of auscultation of brachial artery, the method which is widely used today.
  • 4. The term essential hypertension ('Essentielle Hypertonie') was coined by Eberhard Frank in 1911 to describe elevated blood pressure for which no cause could be found. Thomas Young - Hypertension as a disease 1808 Malignant hypertension, a term used to describe severe hypertension which eventually resulted in death, was first used by The Mayo Clinic in 1928.
  • 5. “Hypertension may be an important compensatory mechanism which should not be tampered with, even were it certain that we could control it”. –Paul Dudley White, Father of Preventive Cardiology.
  • 6. FRANKLIN D. ROOSEVELT The 32nd President of the United States
  • 7. President Franklin D. Roosevelt was given a clean bill of health by his physician even when his BP was recorded as ~220/120. A few years later while at Yalta, Winston Churchill’s personal physician noted in his diary that President Roosevelt “appeared to be have had signs of ‘hardening of the arteries disease’ and had a few months to live.” President Roosevelt ultimately had a fatal hemorrhagic stroke 2 months later, and his death brought hypertension’s potential as a deadly to the limelight. Three years after Roosevelt’s death, the pivotal National Heart Act was signed into law by President Truman. The Act created the path for the study of heart diseases and resulted in several studies including the Framingham Heart Study.
  • 9. Schematic model of the evolution of understanding and approaches to hypertension in the 20th century.
  • 11.
  • 12.
  • 13. Miguel Ondetti and David Cushman, 1975 developed Captopril, the first of a new class of drugs known as angiotensin converting enzyme (ACE) inhibitors. James Whyte Black, 1962 Developed propranolol, a beta blocker used for the treatment of heart disease
  • 14. I wish I had my betablockers handy -Dr. James Black, 1988
  • 15.
  • 16. Evolution of Blood Pressure Clinical Practice Guidelines
  • 17.
  • 18.
  • 19. Conclusion: This study showed the clinical efficacy, safety and acceptability of the perindopril/indapamide/amlodipine SPC in patients with grade 2/3 hypertension inadequately controlled with two drug therapy. The clinical effectiveness was observed in more than 96% patients. The benefit of SPC therapy in hypertension control was reconfirmed in this study.
  • 20. Hypertension Screening on Occasion of World Hypertension Day 2022 • Of the approximately 4500 patients screened, around 800+ patients were screened at OGH, Hyderabad. 3565 922 Males Females
  • 22. 22 0 500 1000 1500 2000 2500 3000 3500 4000 4500 5000 BMI ≥24.0 kg/m2 (Over weight/Obesity) > = 24.0(over weight/Obesity) 70.8 %